Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Samplix

Main Focus:
Preparation of cell samples for functional analysis in a single-cell format; preparation of DNA for validation of gene editing

Company Stage:
Research

Technology | Tool:
Xdrop and Xdrop Sort instruments and consumables

Funding Stage:
Private

Location:
Birkerød, Denmark

Website:
https://samplix.com

Samplix is the home of two unique microfluidics instruments: Xdrop and Xdrop Sort. They are designed to support engineered gene and cell therapy research by making it possible to validate gene edits and viral integrations; assess for on- and off-target rearrangements; and perform functional analyses of cells in a single-cell format. They are the only two instruments for encapsulating DNA fragments or living cells in highly stable, picoliter-sized, double-emulsion droplets that are suitable for PCR, flow cytometry, or sorting. Contact us to learn more.

Downloads

DownloadLocalizing lentiviral transduction-inserted CAR cassettes in T cells using Xdrop®

Tags

HashtagCompany FeaturedHashtagSamplix

Company: Samplix
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine